APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12,619 | +30.2% | 138,513 | -26.1% | 0.02% | +38.5% |
Q4 2022 | $9,691 | -100.0% | 187,413 | -45.7% | 0.01% | -60.6% |
Q3 2022 | $23,571,000 | +1745.8% | 345,113 | +1607.6% | 0.03% | +1550.0% |
Q2 2021 | $1,277,000 | -92.0% | 20,211 | -94.6% | 0.00% | -90.0% |
Q1 2021 | $16,027,000 | +29.5% | 373,513 | +72.7% | 0.02% | +53.8% |
Q4 2020 | $12,373,000 | +1972.5% | 216,313 | +1008.6% | 0.01% | – |
Q4 2019 | $597,000 | +16.8% | 19,513 | -25.5% | 0.00% | – |
Q1 2019 | $511,000 | – | 26,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |